1. oxygen dependent on nasal canula greater than 2-l per minute 2. dependent on inhaled corticosteroid at the discretion of the physician 3. unable to complete any of the outcomes measured (spirometry, 6mwd, sf-36, etc.) 4. active known secondary bacterial or viral infection 5. active moderate or severe post-ards reactive airway disease at the discretion of the physician 6. pre-morbid copd 7. medication list will be reviewed on a case by case basis to allow for flexibility as post-covid-19 patients' medication list may vary 8. other medical comorbidities/conditions that may preclude participation in the study

1. oxygen dependent on nasal canula greater than 2-l per minute 2. dependent on inhaled corticosteroid at the discretion of the physician 3. unable to complete any of the outcomes measured (spirometry, 6mwd, sf-36, etc.) 4. active known secondary bacterial or viral infection 5. active moderate or severe post-ards reactive airway disease at the discretion of the physician 6. pre-morbid copd 7. medication list will be reviewed on a case by case basis to allow for flexibility as post-covid-19 patients' medication list may vary 8. other medical comorbidities/conditions that may preclude participation in the study

oxygen dependent on nasal canula greater than 2-l per minute dependent on inhaled corticosteroid at the discretion of the physician unable to complete any of the outcomes measured (spirometry, 6mwd, sf-36, etc.) active known secondary bacterial or viral infection active moderate or severe post-ards reactive airway disease at the discretion of the physician pre-morbid copd medication list will be reviewed on a case by case basis to allow for flexibility as post-covid-19 patients' medication list may vary other medical comorbidities/conditions that may preclude participation in the study

oxygen dependent on nasal canula greater than 2-l per minute dependent on inhaled corticosteroid at the discretion of the physician unable to complete any of the outcomes measured (spirometry, 6mwd, sf-36, etc.) active known secondary bacterial or viral infection active moderate or severe post-ards reactive airway disease at the discretion of the physician pre-morbid copd medication list will be reviewed on a case by case basis to allow for flexibility as post-covid-19 patients' medication list may vary other medical comorbidities/conditions that may preclude participation in the study

1. oxygen dependent on nasal canula greater than 2-l per minute 2. dependent on inhaled corticosteroid at the discretion of the physician 3. unable to complete any of the outcomes measured (spirometry, 6mwd, sf-36, etc.) 4. active known secondary bacterial or viral infection 5. active moderate or severe post-ards reactive airway disease at the discretion of the physician 6. pre-morbid copd 7. medication list will be reviewed on a case by case basis to allow for flexibility as post-covid-19 patients' medication list may vary 8. other medical comorbidities/conditions that may preclude participation in the study

1. oxygen dependent on nasal canula greater than 2-l per minute 2. dependent on inhaled corticosteroid at the discretion of the physician 3. unable to complete any of the outcomes measured (spirometry, 6mwd, sf-36, etc.) 4. active known secondary bacterial or viral infection 5. active moderate or severe post-ards reactive airway disease at the discretion of the physician 6. pre-morbid copd 7. medication list will be reviewed on a case by case basis to allow for flexibility as post-covid-19 patients' medication list may vary 8. other medical comorbidities/conditions that may preclude participation in the study